A phase 1/2 trial in colorectal cancer, run by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, now recruiting.
Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients is a phase 1/2, interventional study registered as NCT06202001 by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, with a registry enrolment figure of 70 participants, started 2022-10-01 and due to reach its primary completion in 2025-09-30. Interventions recorded: Irinotecan, Trifluridine/tipiracil (TAS-102) plus Bevacizumab. Conditions listed: Metastatic Colorectal Cancer. Primary outcome: Objective Response Rate (ORR). Colorectal eligibility wording from the registry: "Colorectal adenocarcinoma confirmed histologically or histopathologically". Sites: China. No results are recorded here; the registry entry is the source.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.